Expression of Ezrin,HGF,C-met in pancreatic cancer and non-cancerous pancreatic tissues of rats

被引:7
|
作者
Xing-Guo Tan and Zhu-Lin Yang Research Laboratory of Hepatobiliary Diseases
机构
关键词
pancreatic neoplasms; animal model; Ezrin; hepatocyte growth factor; C-met;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
摘要
BACKGROUND:Recent studies have confirmed that the expression of Ezrin,hepatocyte growth factor(HGF)and its receptor(C-met)is related to the genesis,progress,invasion and metastasis of some malignant tumors.Researches have also found that the biological function of Ezrin is closely related to HGF/C-met in malignant tumors.However,there is no report on the expression levels of Ezrin,HGF and C-met in rat pancreatic cancer induced by dimethylbenzanthracene (DMBA).This study aimed to detect the expression of Ezrin, HGF and C-met in rat pancreatic cancer and non-cancerous pancreatic tissues,and assess its effect in cancer induction by DMBA. METHODS:Ninety Sprague-Dawley rats were divided into 3 groups randomly:40 in a pancreatic cancer model group (group A),40 in a trichostatin A(TSA)intervention group (group B),and 10 in a control group(group C).DMBA was directly implanted into the parenchyma of rat pancreas in group A+group B.The rats of group B were treated with 1 ml of TSA saline solution(1μg/ml)via intraperitoneal injection weekly.The carcinogenesis of rats executed within 3-5 months in groups A and B was observed by macrograph and microscopy. Meanwhile,the rats in group C were executed within 5 months. The EnVision TM immunohistochemistry for detecting the expression levels of Ezrin,HGF and C-met was used in paraffinembedded sections of the pancreatic specimens. RESULTS:The incidence of pancreatic cancer in group A was 48.6%and in group B 33.3%.The maximal diameter of tumor mass was significantly larger in group A than that in group B(P<0.05).No pathological changes were observed , in the pancreas of group C and other main organs of groups A and B.The positive rates of Ezrin,HGF and C-met were significantly higher in ductal adenocarcinoma than in non- cancerous pancreatic tissues of groups A and B(P<0.01).The positive rates of Ezrin,HGF and C-met were significantly higher in ductal adenocarcinoma of group A than those in non- cancerous pancreatic tissues of group A(P<0.05),but there was no significant difference in group B(P>0.05).The positive rates of Ezrin,HGF and C-met in non-cancerous pancreatic tissues proved mild to severe atypical hyperplasia of the ductal epithelia.The pancreas of group C and 2 cases of fibrosarcoma showed the negative expression of Ezrin,HGF and C-met.There was a trend of consistency in the expression of Ezrin,HGF and C-met in ductal adenocarcinoma(P<0.05 or P<0.01). CONCLUSIONS:DMBA directly implanted into the parenchyma of the pancreas can produce a model of pancreatic cancer with a high incidence in a short time.TSA might inhibit the carcinogenesis and growth of pancreatic cancer,and its effects may be related to the inhibition of the expression of Ezrin,HGF and C-met during the process.Ezrin,HGF and C-met may have positive effects on the carcinogenesis of rat pancreas.
引用
收藏
页码:639 / 644
页数:6
相关论文
共 50 条
  • [41] c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
    Li, Chenwei
    Wu, Jing-Jiang
    Hynes, Mark
    Dosch, Joseph
    Sarkar, Bedabrata
    Welling, Theodore H.
    di Magliano, Marina Pasca
    Simeone, Diane M.
    GASTROENTEROLOGY, 2011, 141 (06) : 2218 - U395
  • [42] Expression HGF/SF and C-MET in invasive ductal carcinomas
    Bilgin, G.
    Pestereli, E. H.
    Colak, T.
    Erdogan, G.
    Karaveli, S. F.
    VIRCHOWS ARCHIV, 2009, 455 : 98 - 98
  • [43] The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials
    Varkaris, Andreas
    Corn, Paul G.
    Gaur, Sanchaika
    Dayyani, Farshid
    Logothetis, Christopher J.
    Gallick, Gary E.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (12) : 1677 - 1684
  • [44] Expression of HGF and c-Met Proteins in Human Keratoconus Corneas
    You, Jingjing
    Wen, Li
    Roufas, Athena
    Hodge, Chris
    Sutton, Gerard
    Madigan, Michele C.
    JOURNAL OF OPHTHALMOLOGY, 2015, 2015
  • [45] RON and c-met differentially regulate microRNA expression during pancreatic carcinogenesis
    Yu, Peter Tze-Wei
    Lowy, Andrew M.
    Aronow, Bruce
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 209 (03) : S118 - S118
  • [46] Prognostic Value of c-MET Expression in Patients With Pancreatic Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation Therapy
    Cuneo, Kyle C.
    Morgan, Meredith A.
    Griffith, Kent A.
    Hawkins, Peter G.
    Greenson, Joel K.
    Ben-Josef, Edgar
    Lawrence, Theodore S.
    Zalupski, Mark M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (02): : 490 - 497
  • [47] Expression of a novel immunoglobulin gene SNC73 in human cancer and non-cancerous tissues
    Hu, JB
    Zheng, S
    Deng, YC
    WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (05) : 1054 - 1057
  • [48] EXPRESSION OF C-MET PROTOONCOGENE PRODUCT HGF RECEPTOR IN HELICOBACTER-PYLORI-ASSOCIATED GASTRIC TISSUES
    SUGIYAMA, T
    AWAKAWA, T
    SAKAI, M
    SASAKI, S
    IMAI, K
    YABANA, T
    YACHI, A
    GASTROENTEROLOGY, 1994, 106 (04) : A188 - A188
  • [49] c-Met: a New Cancer Stem Cell Marker and Therapeutic Target for Pancreatic Cancer
    Wu, J-J.
    Li, C.
    Hynes, M.
    Dosch, J.
    Sarkar, B.
    Magliano, M. P.
    Simeone, D. M.
    PANCREAS, 2011, 40 (08) : 1363 - 1363
  • [50] c-Met signaling in the development of tumorigenesis and chemoresistance: Potential applications in pancreatic cancer
    Delitto, Daniel
    Vertes-George, Eva
    Hughes, Steven J.
    Behrns, Kevin E.
    Trevino, Jose G.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (26) : 8458 - 8470